Caris GPSai™
Caris GPSai™ analyzes genomic and transcriptomic data to match a tumor’s molecular signature across 21 cancer types from the Caris database to provide additional insight to help oncologists better manage cancers of unknown primary (CUP) or cases with atypical clinical presentation or clinical ambiguity.
Caris FOLFOXai™
Caris FOLFOXai™ is the first clinically validated, AI-powered molecular predictor of chemotherapy efficacy for mCRC patients.